首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   81723篇
  免费   6167篇
  国内免费   258篇
耳鼻咽喉   934篇
儿科学   2198篇
妇产科学   1268篇
基础医学   11073篇
口腔科学   923篇
临床医学   8653篇
内科学   17464篇
皮肤病学   900篇
神经病学   7873篇
特种医学   3135篇
外科学   13070篇
综合类   959篇
一般理论   94篇
预防医学   6294篇
眼科学   1972篇
药学   5565篇
中国医学   94篇
肿瘤学   5679篇
  2023年   675篇
  2022年   1052篇
  2021年   2437篇
  2020年   1375篇
  2019年   2231篇
  2018年   2553篇
  2017年   1815篇
  2016年   1923篇
  2015年   2250篇
  2014年   3250篇
  2013年   4125篇
  2012年   6594篇
  2011年   6843篇
  2010年   3747篇
  2009年   3292篇
  2008年   5499篇
  2007年   5696篇
  2006年   5280篇
  2005年   5234篇
  2004年   4755篇
  2003年   4355篇
  2002年   3934篇
  2001年   688篇
  2000年   495篇
  1999年   637篇
  1998年   808篇
  1997年   619篇
  1996年   504篇
  1995年   446篇
  1994年   417篇
  1993年   411篇
  1992年   297篇
  1991年   246篇
  1990年   232篇
  1989年   208篇
  1988年   209篇
  1987年   171篇
  1986年   179篇
  1985年   193篇
  1984年   220篇
  1983年   176篇
  1982年   257篇
  1981年   252篇
  1980年   174篇
  1979年   128篇
  1978年   139篇
  1977年   116篇
  1976年   96篇
  1975年   77篇
  1974年   66篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal...  相似文献   
4.
5.
Abstract

Objective

Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies.  相似文献   
6.
7.
8.
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology  相似文献   
9.
Arthroscopic acromioclavicular joint excision is a commonly performed but technically demanding procedure. Incomplete excision can leave residual symptoms. We present a simple, reproducible technique ensuring satisfactory excision of the joint.  相似文献   
10.
Coronavirus disease 2019 (COVID-19) has resulted in many challenges in patient care, especially among high-risk populations such as heart transplant recipients. Patients with heart transplant experience a significantly higher mortality rate with COVID-19 infection, and management is based on extrapolation from clinical trials done on nontransplant patients and from clinical experience. Here we report 4 cases of patients with heart transplant who presented with COVID-19 infection in late 2020. Patients presented with symptoms similar to those seen in the general population. All 4 patients were admitted to the hospital, and they were all treated with dexamethasone. In addition, 2 patients received remdesivir. Immunosuppressive medications were adjusted to maintain adequate levels of immunosuppression but at the same time allow for an adequate immune response against the infection. All patients were discharged alive from the hospital. We then performed a literature review on studies that included heart transplant patients who developed the infection and developed suggestions for a standardized management approach, which we share in this article.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号